Skip to main content
Clinical Trials/JPRN-UMIN000004695
JPRN-UMIN000004695
Recruiting
未知

Health-Related Quality of Life of Premenopausal Women with Breast Cancer Treated with Adjuvant Endocrine Therapy Using Gosereline and Tamoxifen - ZOLTAMQO

Saitama Breast Cancer Clinical Study Group (SBCCSG)0 sites50 target enrollmentDecember 9, 2010

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Saitama Breast Cancer Clinical Study Group (SBCCSG)
Enrollment
50
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 9, 2010
End Date
December 1, 2014
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Saitama Breast Cancer Clinical Study Group (SBCCSG)

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1\.Suffering other active cancers 2\.Having simultaneously diagnosed other cancers or having another invasive cancer diagnosed within past 5 years 3\.Ductal carcinoma in situ 4\.Inflammatory breast cancer 5\.Being pregnant 6\.Being treated with LHRH analogue for other diseases 7\.having severe menopausal symptoms 8\.Being inappropriate by an investigators' decision

Outcomes

Primary Outcomes

Not specified

Similar Trials